-
Something wrong with this record ?
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward
S. Esposito, N. Principi, G. Rezza, P. Bonanni, G. Gavazzi, I. Beyer, M. Sulzner, LP. Celentano, R. Prymula, A. Rappagliosi, J. Sevilla, G. Poland, . ,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
ProQuest Central
from 2002-01-01 to 2 months ago
Nursing & Allied Health Database (ProQuest)
from 2002-01-01 to 2 months ago
Health & Medicine (ProQuest)
from 2002-01-01 to 2 months ago
Family Health Database (ProQuest)
from 2002-01-01 to 2 months ago
Health Management Database (ProQuest)
from 2002-01-01 to 2 months ago
Public Health Database (ProQuest)
from 2002-01-01 to 2 months ago
- MeSH
- Communicable Diseases epidemiology MeSH
- Congresses as Topic MeSH
- Communicable Disease Control MeSH
- Middle Aged MeSH
- Humans MeSH
- Decision Making MeSH
- Aged MeSH
- Preventive Health Services trends MeSH
- Vaccination statistics & numerical data trends MeSH
- Healthy Aging * MeSH
- Health Resources MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Geographicals
- Europe MeSH
The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.
Department of Public Health University Hospital Hradec Kralove Czech Republic
European Center for Disease Control and Prevention Stockholm Sweden
Geriatric Department Vrije Universiteit Brussel Brussels Belgium
Geriatric Medicine University of Grenoble Alpes Grenoble France
Harvard Chan School of Public Health Boston MS USA
National Institute of Health Rome Italy
Public Health Department University of Florence Florence Italy
Sanofi Pasteur MSD Lyon France
Unit Crisis Management and Preparedness in Health European Commission Brussels Belgium
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012436
- 003
- CZ-PrNML
- 005
- 20190408082707.0
- 007
- ta
- 008
- 190405s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.vaccine.2018.08.041 $2 doi
- 035 __
- $a (PubMed)30143273
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Esposito, Susanna $u Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy. Electronic address: susanna.esposito@unimi.it.
- 245 10
- $a Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward / $c S. Esposito, N. Principi, G. Rezza, P. Bonanni, G. Gavazzi, I. Beyer, M. Sulzner, LP. Celentano, R. Prymula, A. Rappagliosi, J. Sevilla, G. Poland, . ,
- 520 9_
- $a The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kontrola infekčních nemocí $7 D003140
- 650 _2
- $a infekční nemoci $x epidemiologie $7 D003141
- 650 _2
- $a kongresy jako téma $7 D003226
- 650 _2
- $a rozhodování $7 D003657
- 650 _2
- $a zdravotnické zdroje $7 D006295
- 650 12
- $a zdravé stárnutí $7 D000073656
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a služby preventivní péče $x trendy $7 D011314
- 650 _2
- $a vakcinace $x statistika a číselné údaje $x trendy $7 D014611
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Principi, Nicola $u Università di Milano, Milan, Italy.
- 700 1_
- $a Rezza, Giovanni $u National Institute of Health, Rome, Italy.
- 700 1_
- $a Bonanni, Paolo $u Public Health Department, University of Florence, Florence, Italy.
- 700 1_
- $a Gavazzi, Gaetan $u Geriatric Medicine, University of Grenoble-Alpes, Grenoble, France.
- 700 1_
- $a Beyer, Ingo $u Geriatric Department, Vrije Universiteit Brussel, Brussels, Belgium.
- 700 1_
- $a Sulzner, Michael $u Unit Crisis Management and Preparedness in Health, European Commission, Brussels, Belgium.
- 700 1_
- $a Celentano, Lucia Pastore $u European Center for Disease Control and Prevention, Stockholm, Sweden.
- 700 1_
- $a Prymula, Roman $u Department of Public Health, University Hospital Hradec Kralove, Czech Republic.
- 700 1_
- $a Rappagliosi, Andrea $u Sanofi Pasteur MSD, Lyon, France.
- 700 1_
- $a Sevilla, Joseph $u Harvard Chan School of Public Health, Boston, MS, USA.
- 700 1_
- $a Poland, Gregory $u Vaccine Research Group, Mayo Clinic, Rochester, NY, USA.
- 700 1_
- $a ,
- 773 0_
- $w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 36, č. 39 (2018), s. 5819-5824
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30143273 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190408082720 $b ABA008
- 999 __
- $a ok $b bmc $g 1391746 $s 1050741
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 36 $c 39 $d 5819-5824 $e 20180822 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
- LZP __
- $a Pubmed-20190405
